obesity drug news today october 2025 glp-1 The first issue of New Scientist for 2026 brings a sharp focus on to weight loss medications. It suggests that weight-loss medications should get cheaper and more accessible (with expiry of New GLP-1 Pill Foundayo (Orforglipron)

The carefully calibrated dosing ratios (5/5/10/5mg) reflect years of clinical experience and research into optimal peptide combinations

Use 2 times daily

The firm believes a combination of factors such as health awareness, aesthetic aspirations, and celebrity endorsements has put glutathione in the limelight in the country

However, in a large study involving people with diabetes who had no comorbidities, GLP-1 RAs were not shown to increase the risk of developing pancreatitis at any time point up through 5 years of use.[ref][ref][ref][ref] The Cleveland Clinic now counsels that GLP-1 RA patients should be screened for pancreatitis risk factors, and a lower dose should be used to reduce the risk of pancreatitis.[ref] Related article : Pancreatitis and Genetic Risk Factors Gastroparesis: Case reports tie semaglutide to a risk of gastroparesis (very slow stomach emptying)

RGSH can inhibit ferroptosis induced by ferroptosis inducers erastin and RSL3 in HK-2 cells A HK-2 cell ferroptosis model was constructed using erastin and RSL3

A typical cycle may last 8-12 weeks , followed by a break of 4-6 weeks